Based on the recent finding in the mechanisms of the regulations of PD-L2 biological behavior, scientists have already designed several combination strategies targeting these regulations for cancer therapy and verified the theories in preclinical studies (Tables 2 and 3 and Fig. 3). This evidence concerns the gene PDCD1LG2 and cancer.